pBFS Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
pBFS-Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression
- Status
- UNKNOWN
- Phase
- NA
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
- Status
- RECRUITING
- Phase
- PHASE3
pBFS-guided High-dose TMS Over DMPFC for Treatment-resistant Major Depressive Disorder
- Status
- UNKNOWN
- Phase
- NA
pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD
- Status
- UNKNOWN
- Phase
- NA
Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder
- Status
- COMPLETED
- Phase
- N/A
Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Relationship Between Major Depression and Periodontal Diseases
- Status
- RECRUITING
- Phase
- N/A
pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression
- Status
- RECRUITING
- Phase
- NA
Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression
- Status
- SUSPENDED
- Phase
- NA
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
- Status
- COMPLETED
- Phase
- N/A
Home-based Non-invasive Brain Stimulation for Treatment-resistant Depression Feasibility, Efficacy and Biomarker of Treatment Response
- Status
- COMPLETED
- Phase
- NA
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
- Status
- RECRUITING
- Phase
- NA
Study of ALTO-300 in MDD
- Status
- RECRUITING
- Phase
- PHASE2
First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)
- Status
- WITHDRAWN
- Phase
- PHASE1
Exosome for Early Diagnosis of Bipolar Affective Disorder
- Status
- UNKNOWN
- Phase
- N/A
Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway
- Status
- RECRUITING
- Phase
- NA
Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative Analytics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A